Observational Study Analysing the Transcriptome and Mutational Status of Thyroid Carcinomas of Follicular Origin with Different Degrees of Malignancy

Launched by IRCCS SYNLAB SDN · Mar 12, 2025

Keywords

ClinConnect Summary

This clinical trial is studying thyroid cancer, specifically looking at different types of thyroid tumors that originate from follicular cells. The researchers want to understand the molecular changes that can make some thyroid cancers more aggressive and harder to treat. They will analyze tissue and blood samples from patients with varying degrees of thyroid cancer to find new markers that could help doctors identify how severe the disease is and whether it might come back after treatment. By using advanced techniques to study the genetic material in these samples, they hope to find important clues about how thyroid cancer develops and progresses.

To participate in this study, you need to be over 18 years old and have thyroid cancer of follicular origin. If you qualify, you’ll provide samples that will be analyzed to help researchers learn more about the disease. This study is currently recruiting participants, and the findings could lead to better ways to diagnose and treat thyroid cancer in the future, making treatment more personalized for each patient.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients of either sex aged \> 18 years with thyroid cancer of follicular origin.
• Exclusion Criteria:
• • Patients who do not fit the inclusion criteria.

Trial Officials